|
Video: What is a Stock Split?
|
|
Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need. Its Specialized BioTherapeutics segment is developing and focused on the commercialization of HyBryte (a proposed name of SGX301), a novel photodynamic therapy (PDT), utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). Development programs in this segment also include expansion of synthetic hypericin (SGX302) into psoriasis and dusquetide (SGX942 and SGX945) for the treatment of inflammatory diseases. According to our SNGX split history records, Soligenix has had 2 splits. | |
|
Soligenix (SNGX) has 2 splits in our SNGX split history database. The first split for SNGX took place on February 10, 2023. This was a 1 for 15 reverse split, meaning for each 15 shares of SNGX owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split. SNGX's second split took place on June 06, 2024. This was a 1 for 16 reverse split, meaning for each 16 shares of SNGX owned pre-split, the shareholder now owned 1 share. For example, a 66.6666666666667 share position pre-split, became a 4.16666666666667 share position following the split.
When a company such as Soligenix conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the SNGX split history from start to finish, an original position size of 1000 shares would have turned into 4.16666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Soligenix shares, starting with a $10,000 purchase of SNGX, presented on a split-history-adjusted basis factoring in the complete SNGX split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
12/09/2014 |
|
End date: |
12/06/2024 |
|
Start price/share: |
$336.00 |
|
End price/share: |
$3.23 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.04% |
|
Average Annual Total Return: |
-37.15% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$96.17 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
02/10/2023 | 1 for 15 | 06/06/2024 | 1 for 16 |
|
|